04 May 2026 12:24 CEST

Issuer

Nekkar ASA

4.5.2026 12:23:55 CEST | Nekkar ASA | Additional regulated information required
to be disclosed under the laws of a member state

The Annual General Meeting of Nekkar ASA will be held on Thursday, 28 May 2026
at 12:00 CET at the company's offices, located at Lumberveien 27, Kristiansand.

Please find attached the notice of the meeting along with relevant appendices.

All documents related to the Annual General Meeting are also available here. -
https://nekkar.com/investors/corporate-governance/general-meetingsThe notice,
including attendance and proxy forms, will be distributed to all shareholders
through VPS.

DISCLOSURE REGULATION

This information is subject to the disclosure requirements pursuant to Section
5-12 the Norwegian Securities Trading Act.

CONTACTS

* Ole Falk Hansen, CEO, +47 988 14 184, ir@nekkar.com

ABOUT NEKKAR ASA

Nekkar (OSE: NKR) is an industrial long-term owner of oceanbased technology
companies. The company invests in and develops technology businesses within
sustainable oceans, robotics and intelligent logistics, and digital solutions.
With a 50-year industrial heritage from Syncrolift, Nekkar applies an active
buy-to-own strategy to build long-term value. The group supports empowered
operating companies with a strong balance sheet and reinvests strategically to
ensure profitability and sustainable growth. As a publicly listed company,
Nekkar has a proven track record of shareholder value creation through
disciplined M&A, financial management, and capital allocation.

ATTACHMENTS

Nekkar_GM_Notice_2026_NORWEGIAN.pdf -
https://kommunikasjon.ntb.no/ir-files/17847326/18887913/9014/Nekkar_GM_Notice_20
26_NORWEGIAN.pdf

Nekkar_GM_Notice_2026_ENGLISH.pdf -
https://kommunikasjon.ntb.no/ir-files/17847326/18887913/9015/Nekkar_GM_Notice_20
26_ENGLISH.pdf


672262_Nekkar_GM_Notice_2026_NORWEGIAN.pdf
672262_Nekkar_GM_Notice_2026_ENGLISH.pdf

Source

Nekkar ASA

Provider

Oslo Børs Newspoint

Company Name

NEKKAR

ISIN

NO0003049405

Symbol

NKR

Market

Euronext Oslo Børs